Skip to main content
Premium Trial:

Request an Annual Quote

Celera Genomics Pockets $32M Following Sale of Discovery Partners Stake

NEW YORK, May 12 (GenomeWeb News) - Celera Genomics has pocketed $32 million after selling its one-third stake in Discovery Partners International, the company said today.


The Applera unit sold 7,222,000 shares of Discovery Partners common stock in a public offering at a price of $5 per share. Celera Genomics took possession of these shares in November 2001after it acquired Axys Pharmaceuticals, which owned them since 2000, according to Celera spokesman Rob Bennett.


Bennett said the companies agreed to the move because DPI wanted to have additional shares on the market for institutional investors, and Celera could find a better use for its money.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.